monoclonal antibodies

 

Overall survival was significantly improved by the administration of first-line pertuzumab, trastuzumab and docetaxel in the CLEOPATRA (Clinical Evaluation of Pertuzumab and Trastuzumab) study.

Read more at:

 
Subscribe to monoclonal antibodies